Back to Search
Start Over
PB2118: PHASE 3 RANDOMIZED STUDY OF LONCASTUXIMAB TESIRINE IN COMBINATION WITH RITUXIMAB (LONCA‐R) VERSUS IMMUNOCHEMOTHERAPY IN PATIENTS WITH R/R DLBCL (LOTIS‐5)
- Source :
- HemaSphere; 2022 Supplement 3, Vol. 6, p1989-1990, 2p
- Publication Year :
- 2022
Details
- Language :
- English
- ISSN :
- 25729241
- Volume :
- 6
- Database :
- Complementary Index
- Journal :
- HemaSphere
- Publication Type :
- Academic Journal
- Accession number :
- 175312174
- Full Text :
- https://doi.org/10.1097/01.HS9.0000851304.16627.3a